B-cell Leukemia
📧 Sign up to get email alerts when something new happens for B-cell Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies [Phase 1]
A Phase 1 study of CLIC-2201 for relapsed/refractory B-cell malignancies is currently recruiting. The conditions covered include various B-c…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors [EARLY_Phase 1]
A Phase 1 trial evaluating universal CAR-T cells (REVO-UWD-19) for refractory or relapsed B-cell malignancies is currently recruiting, spons…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
MacroGenics reports a Phase 1 study of MGD024 in relapsed or refractory hematologic malignancies is currently recruiting across multiple dis…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial) [Phase 1]
This Clinical Trial Update describes BaseCAR-01, a Phase 1 study evaluating bispecific CAR T cells in B-cell malignancies, with recruitment …
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
Clinical trial update describing a follow-up protocol for individuals previously enrolled in CAR-T cell studies, detailing a gene therapy fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CAR2219 CAR-T cells for relapsed or refractory B-cell leukemia and B-cell lymphoma is currently recrui…
-
CLINICAL_TRIALS research · 2018-07-02Clinical Trial Update: CD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell Transplantation [NA]
This clinical trial update discusses a CD19-targeted CAR-T cell therapy approach for minimal residual disease–positive B-cell lymphoma or le…
-
CLINICAL_TRIALS research · 2017-06-23Clinical Trial Update: A Study Evaluating UCART019 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma [Phase 1, Phase 2]
Clinical trial update on UCART019 for relapsed/refractory CD19+ leukemia and lymphoma (Phase 1/2) conducted by Chinese PLA General Hospital.
-
CLINICAL_TRIALS research · 2017-04-28Clinical Trial Update: CAR T Cells for Refractory B Cell Malignancy [Phase 1, Phase 2]
This entry reports an ongoing Phase 1/Phase 2 trial of CAR T cell therapy for refractory B-cell malignancies, including B-cell leukemia and …
-
CLINICAL_TRIALS research · 2016-06-28Clinical Trial Update: Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies [NA]
Clinical trial update regarding Chimeric Antigen Receptor T Cells (CART) therapy for refractory/relapsed B-cell hematologic malignancies.